Method for producing dendritic cells
View Patent ↗Disclosed are embryonic stem cell-derived dendritic cells, genetically modified immature dendritic cells capable of maturation, as well as methods for the production of such cells. In one embodiment, the cells made be produced by a method comprising the steps of providing a population of embryonic stem cells; culturing the embryonic stem cells in the presence of a cytokine or combination of cytokines which brings about differentiation of the embryonic stem cells into dendritic cells; and recovering the dendritic cells from the culture. In a further embodiment, the cells may be genetically modified.
1. A method of inducing interleukin-2 (IL-2) release from a T-cell comprising:
contacting an es dendritic cell (esDC) with an antigen and a T cell, wherein the esDC is a dendritic cell obtained by culturing an embryonic stem cell in vitro;
wherein said contacting induces interleukin-2 release from the T cell.
2. The method of claim 1 , wherein the es-DC is a human es-DC.
3. The method of claim 1 , wherein the antigen is a tumor antigen.
4. The method of claim 1 , wherein the antigen is from an infectious agent.
5. A method of stimulating a lympho-proliferative response comprising contacting a population of cells comprising T lymphocytes with an es-DC, wherein the esDC is a dendritic cell obtained by culturing an embryonic stem cell in vitro,
wherein a lympho-proliferative response is stimulated.
6. The method of claim 5 , wherein the es-DC are human es-DC.
7. The method of claim 5 , wherein the es-DC are allogeneic with respect to the lymphocytes.
8. The method of claim 5 , wherein the contacting further comprises contacting the esDC with an antigen.